Literature DB >> 1719527

A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat.

Z H Zhu1, S Holt, M S el-Lbishi, T Grady, T V Taylor, R E Powers.   

Abstract

Despite the proposal that somatostatin or its stable analogue, octreotide (SMS-201,995), may exert an ameliorating effect on acute pancreatitis, data concerning its beneficial effect in this situation are conflicting. This study examines the effects of octreotide on acute pancreatitis, resulting from the retrograde injection of a bile salt (taurocholate) plus saturating trypsin into the common bile-pancreatic duct of the rat. Octreotide given before the induction of pancreatitis significantly reduced the levels of serum amylase and lipase, ascites amylase concentration, degree of leukocyte infiltration, and focal areas of pancreatic tissue necrosis. In contrast, administration of octreotide as soon as 5 min following induction had no demonstrable ameliorating effects on the pancreatitis. These results indicate that octreotide may have application to prophylaxis of acute pancreatitis in cases where bile salts may play a role in pathogenesis, but may not be beneficial in established acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719527     DOI: 10.1097/00006676-199109000-00016

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.

Authors:  W Uhl; M W Büchler; P Malfertheiner; H G Beger; G Adler; W Gaus
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Octreotide ameliorates glucose intolerance following acute experimental pancreatitis.

Authors:  B Avni; R Haddad; H Kashtan; D Kaplan; E Graf; A Siegal; Y Skornick; O Kaplan
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

3.  A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis.

Authors:  C McKay; J Baxter; C Imrie
Journal:  Int J Pancreatol       Date:  1997-02

4.  Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Savio G Barreto; Colin J Carati; Ann C Schloithe; James Toouli; Gino T P Saccone
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

5.  Beneficial effect of octreotide treatment in acute pancreatitis in rats.

Authors:  J Marton; Z Szasz; Z Nagy; K Jarmay; T Takacs; J Lonovics; A Balogh; G Farkas
Journal:  Int J Pancreatol       Date:  1998-12

6.  Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Ozlem Ozer Cakir; Hasan Esen; Aysun Toker; Huseyin Ataseven; Ali Demir; Hakki Polat
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 7.  Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.

Authors:  M W Büchler; M Binder; H Friess
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 8.  Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?

Authors:  C J McKay; C W Imrie; J N Baxter
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.